The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis

The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis

Abstract Background Nafamostat mesilate decreases the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, no studies have administered nafamostat mesilate after ERCP. So we investigated if the infusion of nafamostat mesilate after ERCP can affect the post-...

Full description

Bibliographic Details
Main Authors: Joo Seong Kim, Sang Hyub Lee, Namyoung Park, Gunn Huh, Jung Won Chun, Jin Ho Choi, In Rae Cho, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Gastroenterology
Subjects:
Nafamostat
Endoscopic retrograde cholangiopancreatography
Post-ERCP pancreatitis
Online Access:https://doi.org/10.1186/s12876-022-02345-3

Internet

https://doi.org/10.1186/s12876-022-02345-3

Similar Items